NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ICM Co., Ltd.

ICM Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttp://icm-bio.com/

Last Round

Growth Equity

May 25, 2021

Total Funding Raised

$45.22M

Company Overview

ICM Co., Ltd. is a biotechnology company that develops recombinant adeno-associated virus (rAAV) gene therapies for incurable degenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

adeno-associated virusAAVgene therapybiotechvector engineeringdrug discoveryosteoarthritis treatmentretinal degenerationgene deliverybiopharmaclinical trialslicensing agreementdegenerative diseaseveterinary medicinebiologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ICM Co., Ltd. Comparables

Compare ICM Co., Ltd. with similar companies based on industry and business-model similarity.

ICM Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genascence Corporation
83%
Coave Therapeutics
81%
MeiraGTx Holdings
77%

ICM Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 25, 2021
Series AJun 1, 2016

ICM Co., Ltd. Investors

Notable investors and investment history

ICM Co., Ltd. investors
InvestorRounds
LB InvestmentGrowth Equity
IMM InvestmentGrowth Equity, Series B
Atinum InvestmentGrowth Equity

ICM Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ICM Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ICM Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2012
Last FundingMay 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.